Carter, P. et al. "Humanization of an anti-p185.sup.HER2 antibody for human cancer therapy". Proceedings of the National Academy of Sciences, USA, 89:4285-4289 (1992). |
Gorman, S.D. et al. "Reshaping a therapeutic CD4 antibody". Proceedings of the National Academy of Sciences, USA 88:4181-4185 (1991). |
Ohtomo, T. et al. "Humanization of Mouse ONS-M21 Antibody with the Aid of Hybrid Variable Regions". Molecular Immunology 32(6):407-416 (1995). |
Queen, C. et al. "A humanized antibody that binds to the interleukin 2 receptor". Proceedings of the National Academy of Sciences, USA 86:10029-10033 (1989). |
Riechmann, L. et al. "Reshaping human antibodies for therapy". Nature 332:323-327 (1988). |
Roguska, M. et al. "Humanization of murine monoclonal antibodies through variable domain resurfacing". Proceedings of the National Academy of Sciences, USA 91:969-973 (1994). |
Routledge, E. et al. "A humanized monovalent CD3 antibody which can activate homologous complement". European Journal of Immunology 21:2717-2725 (1991). |
Schumacher, C.L. et al. "Use of Mouse Anti-Rabies Monoclonal Antibodies in Postexposure Treatment of Rabies". Journal of Clinical Investigation 84:971-075 (1989). |
Studnick, G. et al. "Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues". Protein Engineering 7(6):805-814 (1994). |
Tempest, P. et al. "Reshaping a Human Monoclonal Antibody to Inhibit Human Respiratory Syncytial Virus Infection In Vivo". Bio/Technology 9:266-271 (1991). |
Verhoeyen, M. et al. "Reshaping Human Antibodies: Grafting an Antilysozyme Activity". Science 239:1534-1536 (1988). |